LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype

Nadia Cobo‐Vuilleumier, Silvia Rodríguez‐Fernandez, Livia López‐Noriega, Petra I. Lorenzo, Jaime M. Franco, Christian C. Lachaud, Eugenia Martin Vazquez, Raquel Araujo Legido, Akaitz Dorronsoro, Raul López‐Férnandez‐Sobrino, Beatriz Fernández‐Santos, Carmen Espejo Serrano, Daniel Salas‐Lloret, Nila van Overbeek, Mireia Ramos‐Rodriguez, Carmen Mateo‐Rodríguez, Lucia Hidalgo, Sandra Marin‐Canas, Rita Nano, Ana I. Arroba, Antonio Campos Caro, Alfred CO Vertegaal, Alejandro Martín‐Montalvo, Franz Martín, Manuel Aguilar‐Diosdado, Lorenzo Piemonti, Lorenzo Pasquali, Roman González Prieto, Maria Isabel García Sánchez, Decio L. Eizirik, Maria Asuncion Martínez‐Brocca, Marta Vives‐Pi, Benoit R. Gauthier

Open source

DOI
10.1002/ctm2.70134
Published
2024-12
Container
Clinical and Translational Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70134,
  title = {LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype},
  author = {Nadia Cobo‐Vuilleumier and Silvia Rodríguez‐Fernandez and Livia López‐Noriega and Petra I. Lorenzo and Jaime M. Franco and Christian C. Lachaud and Eugenia Martin Vazquez and Raquel Araujo Legido and Akaitz Dorronsoro and Raul López‐Férnandez‐Sobrino and Beatriz Fernández‐Santos and Carmen Espejo Serrano and Daniel Salas‐Lloret and Nila van Overbeek and Mireia Ramos‐Rodriguez and Carmen Mateo‐Rodríguez and Lucia Hidalgo and Sandra Marin‐Canas and Rita Nano and Ana I. Arroba and Antonio Campos Caro and Alfred CO Vertegaal and Alejandro Martín‐Montalvo and Franz Martín and Manuel Aguilar‐Diosdado and Lorenzo Piemonti and Lorenzo Pasquali and Roman González Prieto and Maria Isabel García Sánchez and Decio L. Eizirik and Maria Asuncion Martínez‐Brocca and Marta Vives‐Pi and Benoit R. Gauthier},
  year = {2024},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.70134},
  url = {https://doi.org/10.1002/ctm2.70134}
}

RIS

TY  - JOUR
TI  - LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
AU  - Nadia Cobo‐Vuilleumier
AU  - Silvia Rodríguez‐Fernandez
AU  - Livia López‐Noriega
AU  - Petra I. Lorenzo
AU  - Jaime M. Franco
AU  - Christian C. Lachaud
AU  - Eugenia Martin Vazquez
AU  - Raquel Araujo Legido
AU  - Akaitz Dorronsoro
AU  - Raul López‐Férnandez‐Sobrino
AU  - Beatriz Fernández‐Santos
AU  - Carmen Espejo Serrano
AU  - Daniel Salas‐Lloret
AU  - Nila van Overbeek
AU  - Mireia Ramos‐Rodriguez
AU  - Carmen Mateo‐Rodríguez
AU  - Lucia Hidalgo
AU  - Sandra Marin‐Canas
AU  - Rita Nano
AU  - Ana I. Arroba
AU  - Antonio Campos Caro
AU  - Alfred CO Vertegaal
AU  - Alejandro Martín‐Montalvo
AU  - Franz Martín
AU  - Manuel Aguilar‐Diosdado
AU  - Lorenzo Piemonti
AU  - Lorenzo Pasquali
AU  - Roman González Prieto
AU  - Maria Isabel García Sánchez
AU  - Decio L. Eizirik
AU  - Maria Asuncion Martínez‐Brocca
AU  - Marta Vives‐Pi
AU  - Benoit R. Gauthier
PY  - 2024
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.70134
UR  - https://doi.org/10.1002/ctm2.70134
ER  - 

APA

Cobo‐Vuilleumier, N., Rodríguez‐Fernandez, S., López‐Noriega, L., Lorenzo, P. I., Franco, J. M., Lachaud, C. C., Vazquez, E. M., Legido, R. A., Dorronsoro, A., López‐Férnandez‐Sobrino, R., Fernández‐Santos, B., Serrano, C. E., Salas‐Lloret, D., Overbeek, N. V., Ramos‐Rodriguez, M., Mateo‐Rodríguez, C., Hidalgo, L., Marin‐Canas, S., Nano, R., Arroba, A. I., Caro, A. C., Vertegaal, A. C., Martín‐Montalvo, A., Martín, F., Aguilar‐Diosdado, M., Piemonti, L., Pasquali, L., Prieto, R. G., Sánchez, M. I. G., Eizirik, D. L., Martínez‐Brocca, M. A., Vives‐Pi, M., & Gauthier, B. R. (2024). LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70134

Source records